UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

BMC cancer, 2019-01, Vol.19 (1), p.108-12, Article 108

2019

Volltextzugriff (PDF)

Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment-Comparison with Stage III Disease

Cancers, 2024-03, Vol.16 (6), p.1174

2024

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012

Journal of thoracic oncology, 2013-03, Vol.8 (3), p.373-384

2013

Volltextzugriff (PDF)

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

Journal of clinical oncology, 2015-12, Vol.33 (34), p.4007-4014

2015

Volltextzugriff (PDF)

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.54-64

2017

Volltextzugriff (PDF)

Aktueller Stand der Diagnostik und Therapie des nichtkleinzelligen Lungenkarzinoms (NSCLC) im Stadium III

Der Onkologe, 2018-12, Vol.24 (12), p.974-982

2018

Volltextzugriff (PDF)

The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer

Journal of thoracic oncology, 2024-05, Vol.19 (5), p.786-802

2024

Volltextzugriff (PDF)

Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications

Lung cancer (Amsterdam, Netherlands), 2022-06, Vol.168, p.10-20

2022

Volltextzugriff (PDF)

Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutation

Lung cancer (Amsterdam, Netherlands), 2020-01, Vol.139, p.165-168

2020

Volltextzugriff (PDF)

Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)

Journal of thoracic oncology, 2016-01, Vol.11 (1), p.85-93

2016

Volltextzugriff (PDF)

ERCC1, MLH1, MSH2, MSH6, and βIII-Tubulin: Resistance Proteins Associated With Response and Outcome to Platinum-based Chemotherapy in Malignant Pleural Mesothelioma

Clinical lung cancer, 2013-09, Vol.14 (5), p.558-567.e3

2013

Volltextzugriff (PDF)

Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2012-09, Vol.7 (9), p.1440-1448

2012

Volltextzugriff (PDF)

Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center

European journal of cancer (1990), 2013-10, Vol.49 (15), p.3076-3082

2013

Volltextzugriff (PDF)

Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry

The European respiratory journal, 2023-02, Vol.61 (2), p.2201336

2023

Volltextzugriff (PDF)

The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer

Journal of thoracic oncology, 2016-09, Vol.11 (9), p.1433-1446

2016

Volltextzugriff (PDF)

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

Journal of thoracic oncology, 2016-01, Vol.11 (1), p.39-51

2016

Volltextzugriff (PDF)

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

Journal of thoracic oncology, 2016-03, Vol.11 (3), p.300-311

2016

Volltextzugriff (PDF)

The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non–Small Cell Lung Cancer

Journal of thoracic oncology, 2020-03, Vol.15 (3), p.344-359

2020

Volltextzugriff (PDF)

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors

Journal of thoracic oncology, 2014-09, Vol.9 (9), p.S65-S72

2014

Volltextzugriff (PDF)

The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification

Journal of thoracic oncology, 2016-05, Vol.11 (5), p.639-650

2016

Volltextzugriff (PDF)

The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer

Journal of thoracic oncology, 2014-11, Vol.9 (11), p.1618-1624

2014

Volltextzugriff (PDF)

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the T component for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors

Journal of thoracic oncology, 2014-09, Vol.9 (9), p.S73-S80

2014

Volltextzugriff (PDF)

IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer

Journal of thoracic oncology, 2023-05, Vol.18 (5), p.564-575

2023

Volltextzugriff (PDF)

The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

Journal of thoracic oncology, 2016-05, Vol.11 (5), p.681-692

2016

Volltextzugriff (PDF)

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the N and M Components for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors

Journal of thoracic oncology, 2014-09, Vol.9 (9), p.S81-S87

2014

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

ThemaPrognosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(24)
Oncology
(24)
Science & Technology
(24)
Respiratory System
(19)
Lung Neoplasms - Pathology
(18)
Neoplasm Staging
(16)
Lung Cancer
(11)
Male
(10)
Female
(9)
Aged
(8)
Middle Aged
(8)
Carcinoma, Non-Small-Cell Lung - Pathology
(7)
Lung Neoplasms - Classification
(7)
Survival Rate
(7)
Follow-Up Studies
(6)
Lung Cancer Staging
(6)
Lung Neoplasms - Drug Therapy
(6)
Tnm Classification
(6)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment-Comparison with Stage III Disease

Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer

Aktueller Stand der Diagnostik und Therapie des nichtkleinzelligen Lungenkarzinoms (NSCLC) im Stadium III

The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer

Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications

Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutation

Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)

ERCC1, MLH1, MSH2, MSH6, and βIII-Tubulin: Resistance Proteins Associated With Response and Outcome to Platinum-based Chemotherapy in Malignant Pleural Mesothelioma

Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma

Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center

Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry

The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non–Small Cell Lung Cancer

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors

The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification

The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the T component for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors

IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer

The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the N and M Components for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors

Aktive Filter

Suchergebnisse filtern